Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.29% |
| 2 | Financials | 4.55% |
| 3 | Industrials | 4.18% |
| 4 | Healthcare | 4.08% |
| 5 | Consumer Discretionary | 3.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Atara Biotherapeutics
ATRA
$81.2M
| $4.21M | ﹤0.01% |
10,237
-15,497
| -60% | -$5.34M |
|
3127
Stewart Information Services
STC
$2.08B
| $4.2M | ﹤0.01% |
103,001
+65,709
| +176% | +$2.69M |
|
3128
CALL
Owens Corning
OC
$12.2B
| $4.2M | ﹤0.01% |
64,500
+3,400
| +6% | +$218K |
|
3129
CALL
Wendy's
WEN
$1.65B
| $4.2M | ﹤0.01% |
188,900
-8,400
| -4% | -$178K |
|
|
DBD
3130
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
| $4.2M | ﹤0.01% |
397,300
+193,000
| +94% | +$1.71M |
|
3131
Quanex
NX
$962M
| $4.19M | ﹤0.01% |
245,362
-124,554
| -34% | -$2.34M |
|
3132
PUT
Synaptics
SYNA
$4.25B
| $4.19M | ﹤0.01% |
63,700
+24,300
| +62% | +$1.28M |
|
|
HDV
3133
iShares Core High Dividend ETF
HDV
$15.1B
| $4.18M | ﹤0.01% |
+213,355
| New | +$4.07M |
|
3134
PUT
Polaris
PII
$3.95B
| $4.18M | ﹤0.01% |
41,100
-27,000
| -40% | -$2.62M |
|
|
NLSN
3135
PUT
DELISTED
Nielsen Holdings plc
NLSN
| $4.18M | ﹤0.01% |
205,800
-112,900
| -35% | -$2.29M |
|
3136
PUT
Jabil
JBL
$38B
| $4.17M | ﹤0.01% |
101,000
-47,100
| -32% | -$1.81M |
|
3137
CALL
Brookfield
BN
$107B
| $4.17M | ﹤0.01% |
202,357
+84,362
| +71% | +$1.68M |
|
3138
PUT
Hewlett Packard
HPE
$77.7B
| $4.17M | ﹤0.01% |
263,100
-3,400
| -1% | -$54.3K |
|
3139
iShares Morningstar US Equity ETF
ILCB
$1.32B
| $4.17M | ﹤0.01% |
90,456
+332
| +0.4% | +$14.6K |
|
3140
United Natural Foods
UNFI
$2.93B
| $4.17M | ﹤0.01% |
+475,423
| New | +$3.83M |
|
3141
CALL
Amplify Alternative Harvest ETF
MJ
$110M
| $4.16M | ﹤0.01% |
20,267
+234
| +1% | +$51.6K |
|
3142
Vanguard International Dividend Appreciation ETF
VIGI
$9.29B
| $4.15M | ﹤0.01% |
57,514
+36,943
| +180% | +$2.56M |
|
3143
PUT
WisdomTree
WT
$3.46B
| $4.15M | ﹤0.01% |
858,000
-908,000
| -51% | -$4.51M |
|
3144
CALL
Ligand Pharmaceuticals
LGND
$5.87B
| $4.15M | ﹤0.01% |
63,799
+25,167
| +65% | +$1.68M |
|
|
MFA
3145
MFA Financial
MFA
$926M
| $4.15M | ﹤0.01% |
135,646
-884,779
| -87% | -$27M |
|
3146
CALL
Direxion Daily FTSE China Bull 3X ETF
YINN
$653M
| $4.15M | ﹤0.01% |
9,375
+2,125
| +29% | +$802K |
|
3147
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$249M
| $4.14M | ﹤0.01% |
141,960
+93,895
| +195% | +$2.65M |
|
3148
CALL
Banco Macro
BMA
$4.96B
| $4.14M | ﹤0.01% |
114,200
+85,300
| +295% | +$2.3M |
|
3149
Strategy Inc
MSTR
$36.6B
| $4.14M | ﹤0.01% |
290,300
-249,770
| -46% | -$3.72M |
|
3150
PUT
Camtek
CAMT
$7.72B
| $4.14M | ﹤0.01% |
382,200
-38,500
| -9% | -$401K |
|
Similar funds
Ken Griffin's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Griffin held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin withdrew a net $8.18B in Q4 2019, closing 1,265 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.4% a quarter earlier, followed by Financials and Industrials.
Against the trend, Ken Griffin opened a new position in Interxion Holding N.V. worth $83.9M.
- Ken Griffin's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Ken Griffin added most to Amazon in Q4 2019, an estimated $615M increase.
- Ken Griffin's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Ken Griffin fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Ken Griffin's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Ken Griffin opened 1,220 new positions and closed 1,265 in Q4 2019.
- Ken Griffin's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.